Stock exchanges
AEO Biopharma, Inc. held its Annual Meeting of Stockholders on June 13, 2025, where two proposals were voted on by stockholders. The outcomes of these proposals have been made public through the filing of FORM 8-K with the U.S. Securities and Exchange Commission. The company has also disclosed its
Stock exchanges
At its annual meeting held on June 12, 2025, shareholders of Armata Pharmaceuticals, Inc. elected seven new members to the company's board of directors, each for a one-year term expiring in 2026. The newly elected board members include Deborah L. Birx, M.D., Jules Haimovitz, Odysseas D. Kostas,
Stock exchanges
The Securities and Exchange Commission (SEC) has published a concept release inviting public comment on revising the definition of "foreign private issuer" (FPI) in light of changes in the demographics of FPIs since the definition was originally adopted. The release highlights how the FPI population has evolved over
Securities law
The US Securities and Exchange Commission (SEC) announced on June 10, 2025, that it will immediately resume processing new and pending registration applications for investment advisers with their principal office and place of business in Switzerland. This decision follows discussions between SEC staff and the Swiss Financial Market Supervisory Authority
Stock exchanges
Lyell Immunopharma, a biotechnology company focused on cancer immunotherapy, has made a significant move by increasing its Board of Directors to eight members and appointing Mark Bachleda as a Class I director. This development comes with Dr. Bachleda's term set to expire in 2028, aligning with the Company&
Securities law
Marin Software Incorporated, a Delaware-based company, has filed a Form 8-K (Current Report) with the U.S. Securities and Exchange Commission (SEC) on June 9, 2025. The report discloses significant updates regarding the company's potential transaction with a private equity firm and its plan for voluntary dissolution. Key
Securities law
Plus Therapeutics, Inc. received a notification from the Nasdaq Listing Qualifications Department on June 3, 2025, stating that the Company had failed to comply with the Minimum Stockholders' Equity Requirement. Due to the Company's reported stockholders' equity (deficit) of ($23,641,000) in its Quarterly Report
Stock exchanges
Redfin Corporation, a leading real estate brokerage firm, has filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) announcing the completion of a special meeting of stockholders held on June 4, 2025. The meeting was convened to vote on a proposed merger between Redfin and Rocket
Securities law
Bodhi Tree Biotechnology Inc., a biotechnology company, has filed a corrected Form 8-K with the U.S. Securities and Exchange Commission (SEC) on June 6, 2025, following an immaterial inaccuracy in its initial registration statement on Form S-1. The company disclosed that 55 accredited investors participated in a private placement
United States. Securities and Exchange Commission
Boston-based Elevation Oncology, Inc., a company specializing in the discovery and development of selective cancer therapies for patients with solid tumors, has announced a definitive merger agreement with Concentra Biosciences, LLC. Concentra will acquire Elevation Oncology in a cash transaction, with each share valued at $0.36 plus one non-tradeable
Securities law
The Association of Securities Dealing Houses of Nigeria (ASHON) has called on the Securities and Exchange Commission (SEC) to provide a transition window for capital market operators to adapt to the newly signed Investment and Securities Act 2025. The association seeks a cooling-off period to understand the updated regulatory provisions,
Stock offerings
UMB Financial Corporation (Nasdaq: UMBF) has announced the launch of an underwritten public offering of depositary shares, each representing a 1/400th ownership interest in its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. The depositary shares will be listed on The Nasdaq Global Select Market. RBC Capital Markets, LLC
